Title 21 CFR and Its Recommendations
The title 21 CFR is a part of the Code of Federal Regulations (CFR) permanent rules published in the Federal Register by the Executive departments and agencies of the Federal Government. It is allocated to the rules of the Food and Drug Administration. As with other titles of the CFR Title 21 is also revised once a year. Title 21 CFR and its recommendations are illustrated above in this article with details and examples. Title 21 CFR and Its Recommendations in Part 211 of the FDA’s rule book define the use of electronic data instead of physical paper records. It clarifies the conditions for electronic data that can be accepted by the FDA and other regulatory bodies for the Pharmaceutical industry.
21 CFR Part 210 | 21 CFR Part 211 in Quality Assurance
In the 21 CFR, 21 CFR Part 210 is associated with the manufacturing of drugs which also include manufacturing, processing, packaging, and holding of drug products.
On the other hand, 21CFR Part 211 is associated with finished products of pharmaceuticals. This guidance is related to the Food and Drugs Department and the pharmaceutical industry.
ALSO READ: MHRA guidelines for quality manufacturer of pharmaceutical formulations
21 CFR Part 210 and 21 CFR Part 211 in relation to cGMP.
There are specific guidances for cGMP in 21 CFR Part 210 and 21 CFR Part 211. Current Good Manufacturing Practice for Finished Pharmaceuticals.
1. Subpart AGeneral Provisions.
2. Subpart BOrganization and Personnel.
3. Subpart CBuildings and Facilities.
4. Subpart DEquipment.
5. Subpart EControl of Components and Drug Product Containers and Closures.
6. Subpart FProduction and Process Controls
7. Subpart G Packaging and Labeling Control
8. Subpart HDistribution and Holding.
9. Subpart ILaboratory Controls.
10. Subpart J Reports and Records.
11Subpart KReturned and Salvaged Drug Products.
ALSO READ: Top 5 pharma companies in US
CFR 21 Part 11 compliance
To achieve compliance with 21 CFR Part 211 a manager of a regulatory-controlled manufacturing pharmaceutical company for manufacturing medicinal products so as to establish that these all products are safe and fit for their intended use and will not place patients’ health at risk. The safety, quality, and efficacy are up to the standard requirements. 21 CFR Part 21 compliance is the sole responsibility of top-level management and competent staff like QA and QC Managers.
There is a requirement for a comprehensively designed Quality Assurance system in the company to achieve 21 CFR Part 211 compliance. Incorporation of GMP, Quality Control system, and QRM ( Quality Risk Management) are also the most necessary requirements for compliance with part 211 of 21 CFR.
ALSO READ: What is Pharma Production Linked Incentive Scheme?
